Previous studies reported that the over-expression of PD-L1 on most tumor cells can be induced by IFN-γ signaling as an adaptive response to antitumor immunity, which in turn will affect the efficacy of immunotherapies.38 This evidence concerns the gene CD274 and neoplasm.